Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study. Quirke M, Lamoureux F, Arnoult C, Gress G, et al. J Ocul Pharmacol Ther 2025 Apr 18. doi: 10.1089/jop.2024.0165.

Read + Share

Amedeo Smart

Independent Medical Education

Quirke M, Lamoureux F, Arnoult C, Gress G, et al. Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study. J Ocul Pharmacol Ther 2025 Apr 18. doi: 10.1089/jop.2024.0165.
PMID: 40248843